Materion
MTRN
290.72
-21.43
-6.87%
Materion
US · MTRN
#1852 by market cap
Listed 1970
290.72
-21.43
-6.87%
Live - 5344 symbols - heartbeat 77s ago
· 2026-10-08 08:26
Pre-market
286.00
-1.62%
After-hours
290.72
0.00%
- Market cap
- 6.06B
- P/E (TTM)i
- 67.77
- P/Bi
- 6.09
- EPSi
- 3.58
- Div yieldi
- 0.19%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on MTRN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.49, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.04% YoY
Margins
- Gross margin
- 17.28%
- Operating margin
- 6.34%
- Net margin
- 4.19%
Key ratios & quality
- Enterprise valuei
- 6.50B
- Altman Z-Scorei
- 6.49
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.21B | 1.19B | 1.18B | 1.51B | 1.76B | 1.67B | 1.68B | 1.79B |
| Gross profit | 251.36M | 262.69M | 192.63M | 283.76M | 343.88M | 349.04M | 325.99M | 308.63M |
| Selling & admin expenses | 153.49M | 147.16M | 133.96M | 163.78M | 169.34M | 157.91M | 145.59M | 143.06M |
| Research & development | 15.19M | 18.27M | 20.28M | 26.58M | 28.98M | 27.54M | 29.03M | 25.94M |
| Operating profit | 69.42M | 86.61M | 27.42M | 78.25M | 120.65M | 140.49M | 133.66M | 113.25M |
| Pretax profit | 16.60M | 65.54M | 8.28M | 77.33M | 103.10M | 107.83M | 14.90M | 81.54M |
| Tax | -4.45M | 12.14M | -7.19M | 4.85M | 17.11M | 12.13M | 9.01M | 6.72M |
| Net profit | 21.04M | 53.39M | 15.46M | 72.47M | 85.99M | 95.70M | 5.89M | 74.82M |
| Basic EPS | 1 | 3 | 1 | 4 | 4 | 5 | 0 | 4 |
| Diluted EPS | 1.02 | 2.59 | 0.75 | 3.50 | 4.14 | 4.58 | 0.28 | 3.58 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 420.33M | 431.66M | 444.81M | 489.75M | 549.82M | 613.91M |
| Gross profit | 76.18M | 82.66M | 86.12M | 63.67M | 81.84M | 104.34M |
| Selling & admin expenses | 35.45M | 35.04M | 38.26M | 34.32M | 36.20M | 42.32M |
| Research & development | 6.51M | 6.41M | 6.55M | 6.48M | 6.16M | 6.56M |
| Operating profit | 31.34M | 38.40M | 38.62M | 4.89M | 36.87M | 52.86M |
| Pretax profit | 20.94M | 29.16M | 28.11M | 3.33M | 20.91M | 44.50M |
| Tax | 3.25M | 4.02M | 2.70M | -3.24M | 1.53M | 5.74M |
| Net profit | 17.70M | 25.14M | 25.41M | 6.57M | 19.37M | 38.76M |
| Basic EPS | 1 | 1 | 1 | 0 | 1 | 2 |
| Diluted EPS | 0.85 | 1.21 | 1.22 | 0.31 | 0.92 | 1.84 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 439.35M | 537.75M | 464.00M | 627.25M | 690.45M | 709.38M | 724.22M | 789.52M |
| Cash & ST investments | 70.65M | 125.01M | 25.88M | 14.46M | 13.10M | 13.29M | 16.71M | 13.68M |
| Inventory | 214.87M | 236.25M | 250.78M | 361.12M | 423.08M | 441.60M | 441.30M | 461.23M |
| Total assets | 800.34M | 898.43M | 1.06B | 1.61B | 1.69B | 1.76B | 1.70B | 1.80B |
| Total current liabilities | 139.78M | 122.44M | 126.88M | 204.51M | 238.96M | 255.00M | 226.73M | 253.58M |
| Short-term debt | 823.00K | 868.00K | 1.94M | 15.36M | 21.11M | 38.60M | 34.27M | 22.45M |
| Long-term debt | 2.07M | 1.26M | 36.54M | 434.39M | 410.88M | 387.58M | 407.73M | 436.35M |
| Total liabilities | 246,435,000.00 | 252,687,000.00 | 402,230,000.00 | 887,039,000.00 | 891,989,000.00 | 877,673,000.00 | 828,751,000.00 | 859,524,000.00 |
| Total equity | 553.91M | 645.74M | 655.63M | 720.44M | 799.99M | 885.05M | 868.88M | 943.28M |
| Retained earnings | 548.37M | 624.95M | 631.06M | 693.76M | 769.42M | 854.33M | 849.11M | 912.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 759.04M | 735.11M | 776.33M | 789.52M | 875.75M | 869.96M |
| Cash & ST investments | 15.63M | 12.59M | 16.41M | 13.68M | 16.19M | 19.99M |
| Inventory | 439.76M | 444.64M | 467.33M | 461.23M | 493.69M | 487.44M |
| Total assets | 1.75B | 1.74B | 1.79B | 1.80B | 1.88B | 1.87B |
| Total current liabilities | 267.05M | 231.90M | 235.64M | 253.58M | 288.49M | 295.79M |
| Short-term debt | 52.57M | 19.88M | 10.17M | 22.45M | 23.05M | 17.48M |
| Long-term debt | 398.74M | 405.70M | 446.77M | 436.35M | 466.87M | 423.21M |
| Total liabilities | 864,428,000.00 | 830,562,000.00 | 858,594,000.00 | 859,524,000.00 | 920,436,000.00 | 875,830,000.00 |
| Total equity | 887.93M | 910.65M | 934.58M | 943.28M | 956.96M | 994.87M |
| Retained earnings | 864.00M | 886.25M | 908.69M | 912.36M | 928.80M | 964.47M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 76.37M | 99.22M | 101.06M | 90.24M | 115.96M | 144.41M | 87.82M | 103.24M |
| Depreciation & amortization | 35.52M | 41.12M | 42.38M | 44.14M | 53.44M | 61.64M | 68.68M | 69.07M |
| Free cash flow | 42.11M | 72.69M | 33.78M | -12.67M | 38.35M | 24.54M | 7.01M | 23.68M |
| Dividends paid | -8.39M | -8.86M | -9.26M | -9.70M | -10.16M | -10.62M | -11.09M | -11.51M |
| Stock buybacks / issuance | -422.00K | -199.00K | -6.77M | -- | -- | 0 | 0 | -7.84M |
| Ending cash balance | 70.65M | 125.01M | 25.88M | 14.46M | 13.10M | 13.29M | 16.71M | 13.68M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 15.50M | 49.94M | 18.28M | 19.52M | -4.31M | 74.81M |
| Depreciation & amortization | 16.54M | 17.51M | 17.50M | 17.52M | 18.43M | 19.19M |
| Free cash flow | -5.50M | 35.77M | -5.23M | -1.36M | -19.66M | 58.68M |
| Dividends paid | -2.80M | -2.90M | -2.90M | -2.90M | -2.91M | -3.02M |
| Stock buybacks / issuance | -- | -- | 0 | 0 | -- | -- |
| Ending cash balance | 15.63M | 12.59M | 16.41M | 13.68M | 16.19M | 19.99M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.97 | 8.70 | 2.44 | 10.53 | 11.31 | 11.36 | 0.67 | 8.26 |
| ROA %i | 2.62 | 6.13 | 1.62 | 5.44 | 5.21 | 5.54 | 0.34 | 4.28 |
| ROIC %i | 4.23 | 8.51 | 2.58 | 7.65 | 8.18 | 9.20 | 2.41 | 7.20 |
| 5-year avg ROE %i | 5.51 | 5.47 | 4.58 | 5.63 | 7.43 | 8.90 | 7.25 | 8.43 |
| EBIT margin %i | 1.56 | 5.36 | 1.03 | 5.44 | 7.11 | 8.36 | 2.95 | 6.28 |
| FCF / sales %i | 3.49 | 6.13 | 2.87 | -- | 2.18 | 1.47 | 0.42 | 1.33 |
| Current ratioi | 3.14 | 4.39 | 3.66 | 3.07 | 2.89 | 2.78 | 3.19 | 3.11 |
| Quick ratioi | 1.44 | 2.28 | 1.52 | 1.12 | 0.96 | 0.81 | 0.93 | 0.93 |
| Debt / assetsi | 2.26 | 4.19 | 10.94 | 32.55 | 29.84 | 28.01 | 30.46 | 29.55 |
| LT debt / equityi | 3.12 | 5.70 | 17.36 | 70.49 | 60.48 | 51.42 | 55.56 | 54.10 |
| Interest coveragei | 7.61 | 40.26 | 3.13 | 16.78 | 5.71 | 4.44 | 1.43 | 3.66 |
| Revenue CAGR (3Y) %i | 5.61 | 6.94 | 1.07 | 7.74 | 14.02 | 12.28 | 3.70 | 0.56 |
| Net income CAGR (3Y) %i | -13.18 | 27.53 | 10.53 | 51.01 | 17.22 | 83.61 | -56.69 | -4.53 |
| FCF CAGR (3Y) %i | 2.66 | 32.65 | -4.44 | -- | -19.20 | -10.11 | -- | -14.85 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 1.14 | 1.79 | 2.08 | 8.26 | 8.29 | 9.46 |
| ROA %i | 0.57 | 0.92 | 1.06 | 4.28 | 4.22 | 4.99 |
| ROIC %i | 2.55 | 2.53 | 2.62 | 7.20 | 7.20 | 8.10 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.18 | 3.44 | 3.64 | 6.28 | 5.89 | 6.08 |
| FCF / sales %i | 2.44 | 4.61 | 4.71 | 1.33 | 0.50 | 1.55 |
| Current ratioi | 2.84 | 3.17 | 3.29 | 3.11 | 3.04 | 2.94 |
| Quick ratioi | 0.88 | 0.91 | 0.90 | 0.93 | 0.98 | 0.95 |
| Debt / assetsi | 30.63 | 29.37 | 29.65 | 29.55 | 29.96 | 27.34 |
| LT debt / equityi | 54.53 | 53.97 | 55.81 | 54.10 | 56.36 | 49.66 |
| Interest coveragei | 1.64 | 1.81 | 2.00 | 3.66 | 3.60 | 4.16 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Electronic Materials is the largest reported line at 61.11% of revenue, across 3 reported segments.
- Performance Materials follows at 33.87%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Electronic Materials61.11%
Performance Materials33.87%
Precision Optics5.01%
Quote time 2026-10-08 08:26:06 · For reference only, not investment advice and not tailored to your situation.